News | News By Subject | News by Disease News By Date | Search News

Liver or Gallbladder Disorder (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Here's a Look at Allergan (AGN)'s Opportunity in NASH     1/16/2017
Bristol-Myers Squibb (BMY) Slams Down $100 Million to Make a Play Into NASH     11/14/2016
Gilead (GILD) Looking Even Weaker on the R&D Front as It Racks Up Some More Clinical Failures in Q3 Report     11/2/2016
The $40 Billion NASH Market and the 3 Biotechs That Stand to Profit From it     11/2/2016
Massachusetts's Alnylam (ALNY) Falls After Stopping Development of RNAi Liver Disease Candidate ALN-AAT     10/3/2016
Galectin (GALT) Stock Craters After Phase IIa NASH Failure     9/28/2016
This Biotech Has the Upper Hand Over Allergan (AGN) and Gilead (GILD) in the Heated Nash Battle     9/23/2016
Allergan (AGN)'s NASH Spree Continues With $50 Million+ Buyout of San Diego's Akarna Therapeutics     9/21/2016
Gilead (GILD) to Release Data on 9 Clinical Trials Before End of the Year     9/16/2016
Tobira (TBRA) Stock Loses More Than Half Its Value After Phase IIb Trial Miss     7/25/2016
Intercept Pharma (ICPT)'s Liver Drug Wins Accelerated Approval by the FDA     5/31/2016
Struggling Ariad (ARIA)'s Luck Might be Turning Around as Company Eyes Pfizer (PFE)'s ALK Space     4/13/2016
FDA Panel Unanimously Backs Speedy Approval of Intercept Pharma (ICPT)'s Liver Disease Drug Ocaliva     4/11/2016
Jazz Pharma (JAZZ) Finally Bags FDA Approval for Rare Liver Disorder Drug Defitelio     3/31/2016
Three Big Obstacles Bay Area's Raptor (RPTP) Needs to Overcome     3/22/2016

News from Around the Web
4 Small Biotechs That Could Give Gilead (GILD), Merck & Co. (MRK) Pfizer (PFE) Some Competition With NASH     10/7/2016
Citrus Fruits Could Help Prevent Obesity, Universidade Estadual Paulista Study     8/22/2016
Simple Blood Test Developed To Screen For Life-Threatening Liver Disease, Baylor College of Medicine Study     8/11/2016
A Colony Of Fat Mice Hidden In A Norfolk Lab Could Hold The Key For Liver Disease, Eastern Virginia Medical School Study     7/26/2016
Salem Nonprofit, Design That Matters, Creates Device To Treat Jaundice In Developing World     7/21/2016
Even Light Drinkers Should Watch For Fatty Liver Disease, Kumamoto University Study     5/25/2016
How Fasting Helps Fight Fatty Liver Disease, Helmholtz Zentrum Munchen Study     5/10/2016
How Waist Size Can Predict Liver Disease Risk, University Of Milan Study     4/18/2016
Why It Feels So Good To Scratch An Itch, Published In Proceedings Of The Entomological Society Of Washington     2/29/2016
Biotech Startup Pandorum Technologies Creates India’s First 3D Printed Artificial Human Liver Tissue     12/29/2015
Could Image Mapping Offer Way To Do Noninvasive Liver Biopsies?     10/20/2015
New Device Promises Expedited Results For Detecting Liver Toxicity, Nanyang Technological University Study     9/24/2015
"Our Chairs Are Killing Us," Say Sungkyunkwan University School Of Medicine Researchers     9/16/2015
Diabetes Points Stanford University Scientists Toward Old Gallstone Drug     9/15/2015
New Breath Test Shows Possible Biomarker For Liver Disease Diagnosis, University of Birmingham Study     8/12/2015

Press Releases
Galmed Pharmaceuticals Completes Patient Recruitment For ARREST Phase IIb NASH Study     1/9/2017
Can-Fite BioPharma (CFBI) Receives IRB Approval To Commence Patient Enrollment In Phase II NAFLD/NASH Trial In Q1 2017     1/9/2017
HepaRegeniX GmbH Raises €9 Million In A Series A Financing To Develop Kinase Inhibitors For The Treatment Of Acute And Chronic Liver Diseases     1/5/2017
FDA Grants Fast Track Designation To Enanta Pharmaceuticals, Inc.’s FXR Agonist Candidate, EDP-305, For The Treatment Of NASH With Liver Fibrosis     1/4/2017
New Preclinical Data Show Can-Fite BioPharma (CFBI)'s Namodenoson (CF102) Inhibits Liver Fibrosis -- Supports Potential Efficacy In Treatment Of NASH     12/16/2016
European Commission (EC) Grants Intercept Pharma (ICPT)’s Ocaliva (Obeticholic Acid) Marketing Authorization For The Treatment Of Primary Biliary Cholangiti     12/14/2016
Arcturus Therapeutics Announces Collaboration With Takeda (TKPYY) To Develop RNA-Based Therapeutics For The Treatment Of Nonalcoholic Steatohepatitis (NASH)     12/7/2016
Gilead (GILD) Release: Phase 2 Data For Selonsertib In Nonalcoholic Steatohepatitis (NASH) Presented At The Liver Meeting 2016     11/15/2016
Arbutus Biopharma (ABUS) Presents HBV Drug Combination Studies At American Association for Study of Liver Diseases     11/15/2016
Albireo (ALBO)’s Lead Product Candidate For Orphan Pediatric Liver Disease Accepted Into EMA's PRIME Program     11/15/2016
Eiger Biopharma Announces Positive Phase 2 Data At The American Association for Study of Liver Diseases Meeting: Multiple Paths Forward Identified With Lonafarnib Therapy In LOWR HDV Program     11/14/2016
Prometheus BioScience Inc. Provides Update On Hepastem NASH-Fibrosis Program With Late-Breaking Preclinical Data At 2016 American Association for Study of Liver Diseases Meeting     11/14/2016
American Association for Study of Liver Diseases Release: New Genetics Study Shows Fatty Liver Disease Cirrhosis Could Run In Families     11/14/2016
American Association for Study of Liver Diseases Release: Statins Shown To Reduce Risk Of Death In People With Alcoholic Cirrhosis     11/14/2016
Intercept Pharma (ICPT) Presents New Data At American Association for Study of Liver Diseases Examining The Effects Of Ocaliva (Obeticholic Acid) On Non-Invasive Assessments Of Liver Fibrosis In Patients With PBC     11/11/2016